Journal profile · Oncology
Hereditary Cancer in Clinical Practice
ISSN 1731-2302 · eISSN 1897-4287 · BioMed Central · POLAND · Quarterly · Founded 2003
Hereditary Cancer in Clinical Practice: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 2.74; fully open access; APC about USD 2,690; median 107 days to acceptance (58 articles, last 24 months); community-reported acceptance: fairly easy; 28 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Hereditary Cancer in Clinical Practice is published by BioMed Central and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are BRCA gene mutations in cancer, Genetic factors in colorectal cancer and Colorectal Cancer Screening and Detection, together about 53.4% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
Hereditary Cancer in Clinical Practice is an open access journal that publishes articles of interest for the cancer genetics community and serves as a discussion forum for the development appropriate healthcare strategies. Cancer genetics encompasses a wide variety of disciplines and knowledge in the field is rapidly growing, especially as the amount of information linking genetic differences to inherited cancer predispositions continues expanding. With the increased knowledge of genetic variability and how this relates to cancer risk there is a growing demand not only to disseminate this information into clinical practice but also to enable competent debate concerning how such information is managed and what it implies for patient care. Topics covered by the journal include but are not limited to: Original research articles on any aspect of inherited predispositions to cancer. Reviews of inherited cancer predispositions. Application of molecular and cytogenetic analysis to clinical decision making. Clinical aspects of the management of hereditary cancers. Genetic counselling issues associated with cancer genetics. The role of registries in improving health care of patients with an inherited predisposition to cancer.
From the journal's Aims & Scope
Research area (LetPub): Oncology
Editor-in-chief Jan LubinskiPublisher website
Editorial board by country: 1 in mainland China (about 2%); most named Australia 8, Poland 6, United Kingdom 5, Germany 4, United States 3 (43 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- BRCA gene mutations in cancerBiochemistry, Genetics and Molecular Biology23.9%
- Genetic factors in colorectal cancerMedicine23.4%
- Colorectal Cancer Screening and DetectionMedicine6.1%
- Cancer Genomics and DiagnosticsBiochemistry, Genetics and Molecular Biology5.6%
- Genomics and Rare DiseasesBiochemistry, Genetics and Molecular Biology4.5%
- DNA Repair MechanismsBiochemistry, Genetics and Molecular Biology3.3%
- Colorectal Cancer Treatments and StudiesMedicine3%
- Ovarian cancer diagnosis and treatmentMedicine2.8%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Oncology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Oncology | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Oncology | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
EmbaseCASPublisher website
Other: Google Scholar, ProQuest, Dimensions, CNKI, Baidu, Naver, OCLC, Portico, CLOCKSS
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 2.74LetPub ·
- Impact factor (publisher) 2025
- 2.8Publisher website ·
- 5-year impact factor (publisher) 2025
- 2.3Publisher website ·
- CiteScore 2026-06
- 4.3LetPub ·
- SJR 2026-06
- 1.05LetPub ·
- SNIP 2026-06
- 0.94LetPub ·
- h-index
- 21LetPub ·
- h-index
- 42OpenAlex ·
- i10-index
- 245OpenAlex ·
- 2-year mean citedness
- 2.54OpenAlex ·
- Self-citation rate
- 3.6%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 27LetPub ·
- Downloads per year (publisher) 2025
- 416,000Publisher website ·
Articles by year OpenAlex count · 845 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 27 | 27 | 4 |
| 2025 | 28 | 28 | 52 |
| 2024 | 27 | 27 | 152 |
| 2023 | 28 | 28 | 214 |
| 2022 | 38 | 38 | 426 |
| 2021 | 49 | 49 | 414 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
107 daysMedian, submission to acceptance · P25–P75 66 days – 172 days
- Acceptance to online
- median 16 days (58 articles)
- Submission to online
- median 129 days
- Sample
- 58 articles with submission and acceptance dates (62 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- over 12 weeksLetPub ·
- Average acceptance (community reports)
- Fairly easyLetPub ·
- Submission to first decision
- 6 daysPublisher website ·
- Peer review
- Open peer reviewLetPub
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessOpenAlex
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 2,690 / EUR 2,290 / GBP 1,990 | — | — | |
| LetPub | GBP 1,890 / USD 2,590 / EUR 2,190 | Yes | — | |
| Publisher website | GBP 1,890 / USD 2,590 / EUR 2,190 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare2 items from the author guidelines
- Suggested reviewers
- Optional
- Not considered
- preprint
Article types accepted6
- case reportsResearch Case Reports Comment Debate Correspondence ReviewsLength not stated
- commentResearch Case Reports Comment Debate Correspondence ReviewsLength not stated
- correspondenceResearch Case Reports Comment Debate Correspondence ReviewsLength not stated
- debateResearch Case Reports Comment Debate Correspondence ReviewsLength not stated
- researchResearch Case Reports Comment Debate Correspondence ReviewsLength not stated
- reviewsResearch Case Reports Comment Debate Correspondence ReviewsLength not stated
Policy excerpts from the journal's websiteData availability, License & copyright, Open access, Peer review
- Data availability Formatting the 'Availability of data and materials' section of your manuscript
CC0 data policy Model summary
The following format for the 'Availability of data and materials section of your manuscript should be used:
Source ↗Publisher website ·- License & copyright Licensing and copyright
CC BY (Creative Commons Attribution 4.0 International licence) Model summary
Creative Commons licences Open access articles in Springer Nature journals are published under Creative Commons licences. These provide an industry-standard framework to support easy re-use of open access material. Under Creative Commons licences, authors retain copyright of their articles. Hereditary Cancer in Clinical Practice articles are published open access under a CC BY (Creative Commons At…
Source ↗Publisher website ·- Open access Benefits of open access
Publishing open access (OA) offers a number of benefits, including greater reach and readership for your work: Cited more 1.6x more citations of OA articles than non-OA articles across all subjects Downloaded more 4x more downloads of OA articles than non-OA articles Greater impact 2.5x more Altmetric attention. OA articles attracted 1.9x more news mentions and 1.2x more policy mentions Open acces…
Source ↗Publisher website ·- Peer review Peer review policy
Peer review is the process used to evaluate the quality of a manuscript before publication. Independent researchers in the relevant field assess submitted manuscripts to check their validity and robustness. Their feedback guides editors in making publication decisions. Typically, two or more experts evaluate each manuscript based on three main criteria: scientific robustness: is the research metho…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- BioMed Central
- Country or region
- POLAND
- Language
- English
- Frequency
- Quarterly
- Founded
- 2003
- ISSN
- 1731-2302
- Electronic ISSN
- 1897-4287
- Society / sponsor
- Hereditary Cancer Cancer Center
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- Special issues ↗Publisher website
- Peer review process ↗LetPub
- Editorial board ↗LetPub
FAQ
Frequently asked questions about Hereditary Cancer in Clinical Practice
What CAS zone is Hereditary Cancer in Clinical Practice in?
In the 2025 upgraded edition of the CAS Journal Ranking, Hereditary Cancer in Clinical Practice is in Zone 4 of Medicine, and in Zone 4 of the minor category Oncology. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Hereditary Cancer in Clinical Practice?
The latest impact factor listed by LetPub is 2.74; CiteScore 4.3, h-index 42.
How long does peer review take at Hereditary Cancer in Clinical Practice?
Based on the dates recorded on 58 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 107 days (interquartile range 66–172 days); authors report an average review time of over 12 weeks; the community-reported acceptance is “Fairly easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of Hereditary Cancer in Clinical Practice based?
Of the 43 board members whose country the journal's board page names, 1 (about 2%) are in mainland China; the countries named most often are Australia (8), Poland (6) and United Kingdom (5). Counted from the institutions listed on the board page; for reference only.
Which databases index Hereditary Cancer in Clinical Practice?
According to LetPub and DOAJ records, Hereditary Cancer in Clinical Practice is indexed in SCIE, Scopus and DOAJ. The journal's website also lists Embase and CAS; that list has not been checked against each database.
Is Hereditary Cancer in Clinical Practice open access, and what is the APC?
Hereditary Cancer in Clinical Practice is a fully open-access journal. APC about USD 2,690.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-24). Last updated: .